Search Results 221-230 of 17717 for Thromboembolism
This potentially serious condition can occur with few or no symptoms. Know the risk factors.
The purpose of this global study is to evaluate transarterial chemoembolization (TACE) in combination with durvalumab and bevacizumab therapy in patients with ...
A blood clot blocks and stops blood flow to an artery in the lung. Often the clot starts in a leg and travels to the lung.
The purpose of this study is to assess the effectiveness and safety of Selexipag in subjects with inoperable or persistent/recurrent Chronic Thromboembolic ...
Primary interests include pulmonary hypertension both WHO Group I, chronic thromboembolic pulmonary hypertension and the role of Balloon Pulmonary ...
Venous thromboembolism: VTE within the past 3 to 12 months, non-severe thrombophilia (e.g. heterozygous factor V Leiden or prothrombin gene mutation) ...
The purpose of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation ...
Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther. 2017 Dec; 7 (Suppl 3):S207-S218 View PubMed; Fleck D, Albadawi H ...
Asiri IM, Chen RC, Master V, Mi L, James SE, Bryce AH, Afzal U, Riaz IB, Ahmed Naqvi SA, Beach SRH, Cobran EK. Thromboembolic Events in Castration-Resistant ...
High risk of developing thromboembolic events, who are unwilling to take venous thromboembolism prophylaxis. Active or prior documented autoimmune or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!